Factor Xa inhibitors

摘要

The invention is concerned with novel heteroaryl fused cyclic amines of formula (I) wherein A, X¹ to X³, Y¹ to Y³, Z, R¹, R², m and n are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit coagulation factor Xa and can be used as medicaments.